US Stock MarketDetailed Quotes

HUMA Humacyte

Watchlist
  • 3.145
  • -0.075-2.33%
Trading Feb 25 09:43 ET
404.66MMarket Cap-2.35P/E (TTM)

About Humacyte Company

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Company Profile

SymbolHUMA
Company NameHumacyte
Listing DateDec 1, 2020
Founded2004
CEOMs. Laura E. Niklason
MarketNASDAQ
Employees185
Fiscal Year Ends12-31
Address2525 East North Carolina Highway 54
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-313-9633

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Laura E. Niklason
  • President, Chief Executive Officer and Director
  • 2.63M
  • Dr. Yang Cao
  • Chief Regulatory Officer
  • --
  • Dr. Heather Prichard
  • Chief Operating Officer
  • 1.27M
  • Shamik J. Parikh
  • Chief Medical Officer
  • --
  • Dale A. Sander
  • Principal Accounting Officer, Chief Financial Officer, Chief Corporate Development Officer and Treasurer
  • 1.35M
  • William John Scheessele
  • Chief Commercial Officer
  • --
  • Kathleen Sebelius
  • Chairman of the Board
  • 96.76K
  • Rajiv Shukla
  • Director
  • 71.76K
  • Brady W. Dougan
  • Director
  • 71.76K
  • Dr. John P. Bamforth
  • Independent Director
  • --
  • Todd M. Pope
  • Independent Director
  • 76.76K
  • C. Bruce Green
  • Independent Director
  • 71.76K
  • Dr. Susan Richards Windham-Bannister, PhD
  • Independent Director
  • 71.76K
  • Dr. Keith Anthony Jones
  • Independent Director
  • --
  • Max Wallace
  • Independent Director
  • 76.76K
  • Diane Seimetz
  • Independent Director
  • 71.76K
  • Michael T. Constantino
  • Independent Director
  • 79.26K
  • Gordon M. Binder
  • Independent Director
  • 71.76K
  • Dr. Emery N. Brown
  • Independent Director
  • 71.76K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. Show More